FDA Inspection 1271683 — Kappa Laboratories, Inc.

Kappa Laboratories, Inc. — FEI 1039390

The FDA completed an inspection of Kappa Laboratories, Inc. on Jun 4, 2025 in Miami, FL. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 3 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Jun 4, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Miami, FL (United States)

Citations

IDCFRDescription
127421 CFR 211.68(a)Calibration/Inspection/Checking not done
361321 CFR 211.160(b)(4)Establishment of calibration procedures
457621 CFR 211.192No written record of investigation

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.